Three life-science prizes were awarded for advances in gene therapies. Opthalmologists Jean Bennett and Albert Maguire, and ...
The global gene therapy market size is projected to expand significantly, with an estimated value of USD 19.3 billion by 2034 ...
The US Food and Drug Administration (FDA) has released draft guidance on how sponsors can utilize next-generation sequencing ...
The Breakthrough Prize Foundation awarded researchers involved in developing gene therapies for blindness and sickle cell ...
Medera Inc. ("Medera"), a clinical-stage biopharmaceutical company developing next-generation cardiovascular therapeutics, and its clinical development division Sardocor, today announced that the U.S.
A domestically developed gene-editing therapy has successfully treated patients with beta-thalassemia, allowing them to live ...
Researchers have developed a modified CRISPR gene-editing tool with potential to silence the extra chromosome causing Down ...
Cell and gene therapies are moving towards correcting root causes of diseases. Let's take a look at future cell and gene therapy trends.
VectorBuilder, a global leader in gene delivery technologies and CDMO solutions, today announced MuteFree™ AAV, a ...
Scientists have taken an important step toward a gene therapy that could one day turn off the extra genetic material that ...
Proprietary capsid engineering supports comparable cardiac gene delivery at 5–10-fold lower vector doses, potentially improving batch economics, easing purification constraints, and widening ...
The FDA’s recently unveiled plausible mechanism framework may have been forged with i | The FDA’s newly launched plausible ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results